See All Slides - tctmd.com

Slides

Presentation Cell Therapy 2013

Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells (Revascor™) in Patients With Chronic Heart Failure of Ischemic or Nonischem

Presenter: Kenneth M. Borow

January 22, 2013

Presentation Cell Therapy 2013

Regenerative Therapies After Acute Myocardial Infarction- Focus on Endpoints

Presenter: Stephen G. Ellis

January 22, 2013

Presentation Cell Therapy 2013

IK 5001 - A Novel Approach to Myocardial Remodeling

Presenter: David F. Kong

January 22, 2013

Presentation

Rheolytic Thrombectomy for Deep Vein Thrombosis: Prospective Multicenter Registry Report

Presenter: Robert A. Lookstein

January 21, 2013

Presentation

Stent Thrombosis: Predisposing Factors and How to Prevent

Presenter: Ajay J. Kirtane

January 21, 2013

Presentation

Paradigm Shift in Ruptured AAA Management

Presenter: Sherif Sultan

January 21, 2013

Presentation

Impact of Endograft Type on Inflammatory Response After Endovascular Treatment of AAA

Presenter: Konstantinos G. Moulakakis

January 17, 2013

Presentation

Contrast-Induced Acute Kidney Injury (AKI) and Risk of Adverse Clinical Outcomes After Coronary Angiography

Presenter: Matthew T. James

January 17, 2013

Presentation

Should Duration of Dual Antiplatelet Therapy Depend on the Type and/or Potency of Implanted Stent?

Presenter: Marco Valgimigli

January 16, 2013

Presentation

Effect on Door-to-Balloon (D2B) Time of Immediate Transradial PCI on Culprit Lesion in STEMI vs. Diagnostic Angiography Followed by Primary PCI

Presenter: G. Plourde

January 16, 2013

Advertisement

Slides

Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells (Revascor™) in Patients With Chronic Heart Failure of Ischemic or Nonischem

Regenerative Therapies After Acute Myocardial Infarction- Focus on Endpoints

IK 5001 - A Novel Approach to Myocardial Remodeling

Rheolytic Thrombectomy for Deep Vein Thrombosis: Prospective Multicenter Registry Report

Stent Thrombosis: Predisposing Factors and How to Prevent

Paradigm Shift in Ruptured AAA Management

Impact of Endograft Type on Inflammatory Response After Endovascular Treatment of AAA

Contrast-Induced Acute Kidney Injury (AKI) and Risk of Adverse Clinical Outcomes After Coronary Angiography

Should Duration of Dual Antiplatelet Therapy Depend on the Type and/or Potency of Implanted Stent?

Effect on Door-to-Balloon (D2B) Time of Immediate Transradial PCI on Culprit Lesion in STEMI vs. Diagnostic Angiography Followed by Primary PCI

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content